渐进抗阻训练联合A型肉毒毒素对痉挛型脑瘫患儿下肢肌痉挛及运动能力的影响OA
Effects of Progressive Resistance Training Combined with Type A Botulinum Toxin on Lower-Limb Muscle Spasticity and Motor Ability in Children with Spasticity Cerebral Palsy
目的:研究渐进抗阻训练(PRT)联合A型肉毒毒素(BTX-A)对痉挛型脑瘫(SCP)患儿下肢肌痉挛及运动能力的影响.方法:本研究为前瞻性研究,选取 2021年1月~2023 年12 月于本院治疗的 80 例SCP患儿作为研究对象,采用随机数字表法分为对照组(BTX-A)和观察组(PRT联合BTX-A),每组40例.观察治疗前后两组患儿下肢肌痉挛情况[改良阿什沃思量表(MAS)评分]、步态变化情况(步宽、步长和步速)、运动能力情况[粗大运动功能评估量表88(GMFM-88)评分]及不良反应发生情况.结果:治疗后,两组患儿MAS评分均降低,且观察组低于对照组(P<0.05);步宽均缩短,且观察组短于对照组(P<0.05);步长均增长,且观察组长于对照组(P<0.05);步速均增快,且观察组快于对照组(P<0.05);GMFM-88的D区、E区及D+E区总分均升高,且观察组高于对照组(P<0.05).两组患儿注射部位疼痛发生率比较无统计学差异(P>0.05);观察组一过性肌无力发生率(42.50%)低于对照组(65.00%,P<0.05).结论:PRT联合BTX-A治疗可以缓解SCP患儿下肢肌痉挛,纠正异常步态,提高患儿运动能力,降低一过性肌无力的发生率.
Objective:To investigate the effects of progressive resistance training(PRT)combined with type A botulinum toxin(BTX-A)on lower-limb muscle spasticity and motor ability in children with spasticity cerebral palsy(SCP).Methods:This prospective study included 80 children with SCP treated at our hospital from January 2021 to December 2023.They were randomly divided into a control group(BTX-A)and an observation group(PRT combined with BTX-A)using a random number table method,with 40 cases in each group.Lower-limb muscle spasticity[Modified Ashworth Scale(MAS)score],gait parameters(step width,step length and walking speed),motor ability[Gross Motor Function Measure-88(GMFM-88)scores],and adverse reactions were observed before and after treatment in both groups.Results:After treatment,MAS scores decreased in both groups and were lower in the observation group than in the control group(P<0.05).Step width decreased and was shorter in the observation group than in the control group(P<0.05);step length increased and was longer in the observation group than in the control group(P<0.05);walking speed increased and was faster in the observation group than in the control group(P<0.05).GMFM-88 dimension D and E scores and their combined total score increased and were higher in the observation group than in the control group(P<0.05).There was no statistically significant difference in the incidence of injection-site pain between the two groups(P>0.05).The incidence of transient muscle weakness was lower in the observation group(42.50%)than in the control group(65.00%,P<0.05).Conclusion:PRT combined with BTX-A can alleviate lower-limb muscle spasticity,correct abnormal gait,improve motor ability,and reduce the incidence of transient muscle weakness in children with SCP.
牛冬林;马丹丹;罗丽;程明高;刘锋伟
郑州大学第三附属医院,郑州 450000郑州大学第三附属医院,郑州 450000郑州大学第三附属医院,郑州 450000郑州大学第三附属医院,郑州 450000郑州大学第三附属医院,郑州 450000
医药卫生
渐进抗阻训练A型肉毒毒素痉挛型脑瘫下肢肌痉挛运动能力
progressive resistance trainingtype A botulinum toxinspasticity cerebral palsylower-limb muscle spasticitymotor ability
《中国合理用药探索》 2026 (7)
28-33,6
河南省医学科技攻关计划项目(LHGJ20200426)
评论